Compounding Pharmacy in Houston, Texas: The 2026 Patient & Provider Guide

Introduction: Why Choosing a Compounding Pharmacy in Houston, Texas Requires More Than a Google Search

When a physician, dermatologist, endocrinologist, pain specialist, or veterinarian determines that a patient needs a custom medication, the next step is usually a search for “compounding pharmacy Houston.” The results are mostly thin directory listings on Yelp, Facebook, and aggregator sites. They show hours, addresses, and a few reviews, but they say almost nothing about licensing, safety, or regulatory standing.

This guide fills that gap in two ways. First, it explains how compounding is regulated: the Texas State Board of Pharmacy (TSBP), the 891 sterile-compounding pharmacies operating statewide as of July 2025, the 503A/503B distinction, the March 1, 2026 sterile compounding rule update, and the 2025 GLP-1 enforcement deadlines. Second, it offers a practical vetting framework that works for any Houston-area storefront or nationwide-licensed compounder.

The guide is written for patients, caregivers, and prescribers, including MDs, NPs, PAs, med spas, and telehealth platforms. The 2026 rule change and the 2025 GLP-1 enforcement deadlines have reshaped this market, making careful evaluation more important than it was a year or two ago.

Understanding Texas’s Compounding Pharmacy Market

Texas is one of the largest compounding markets in the United States. As of July 2025, 891 Class A, B, C, and E pharmacies in the state perform sterile compounding. Houston is a major metro within this high-volume, heavily regulated market. Its compounders include:

• Legacy independent pharmacies
• Bioidentical hormone replacement therapy (BHRT) specialists
• Veterinary-only compounders

The Texas State Board of Pharmacy is the primary state regulator. It oversees pharmacy licensing, inspections, and discipline.

A license, however, is only a minimum requirement. It shows that a pharmacy may legally operate. It does not show how well that pharmacy controls quality, sources ingredients, or tests finished products. Those questions require a closer look.

The 503A vs. 503B Distinction Every Houston Patient and Provider Should Understand

Federal law recognizes two types of compounders.

503A pharmacies are traditional compounding pharmacies.

• They prepare medications based on a valid, patient-specific prescription.
• State boards of pharmacy, such as TSBP, handle most of their day-to-day oversight, rather than the FDA.
• This is the dominant model, representing roughly 72% to 81% of U.S. compounding market revenue. Most Houston patients will use a 503A pharmacy.

503B “outsourcing facilities” serve a different purpose.

• They are registered with the FDA and inspected under current Good Manufacturing Practice (cGMP) standards.
• They can produce bulk, office-use orders that are not tied to a specific patient. Clinics and hospitals are their main customers.

The practical difference is simple. An individual prescription usually goes through a 503A pharmacy. A clinic stocking products for office use typically needs a 503B facility. Providers should understand this distinction before referring patients or placing orders. In essentially all cases, a compounded medication also requires a valid prescription from a licensed prescriber.

What Changed on March 1, 2026: Texas’s Updated Sterile Compounding Rules

TSBP’s updated sterile compounding rules took effect March 1, 2026. They apply to anyone in Houston receiving sterile injectables, IV preparations, or hormone pellets.

Texas sterile compounding standards are found in the Texas Administrative Code (22 TAC). These rules cover:

• Sterile preparation standards
• Media-fill testing, which checks whether staff can maintain sterility during compounding
• Pharmacist oversight requirements

Patients and providers should take two practical steps:

1. Confirm the pharmacy’s current TSBP licensing status.
2. Ask directly whether the pharmacy’s sterile operations have been updated and inspected under the March 1, 2026 standard.

Why Regulation Exists: The NECC Outbreak and the Birth of Modern Compounding Oversight

In 2012, the New England Compounding Center (NECC) shipped contaminated steroid injections that caused a fungal meningitis outbreak. According to the CDC, 753 people were sickened and 64 died. The tragedy led directly to the federal 503A/503B framework in place today.

NECC is the clearest reason why accreditation, USP compliance, and third-party testing are patient-safety necessities, not bureaucratic box-checking. It is also why a structured vetting process tells patients far more than a storefront’s hours.

The 2025 GLP-1 Compounding Shutdown: What It Means for Houston Patients in 2026

Shortage timeline. The FDA declared the tirzepatide shortage resolved in December 2024 and the semaglutide shortage resolved on February 21, 2025.

The resulting rule. Once those shortages ended, compounding a product that is “essentially a copy” of an FDA-approved GLP-1 drug was no longer permitted for 503A or 503B compounders. Narrow exceptions remain, such as customized formulations that do not duplicate the brand product.

Enforcement deadlines for semaglutide copies:

• 503A pharmacies could compound these products only until April 22, 2025.
• 503B facilities had until May 22, 2025.
• Enforcement discretion for tirzepatide ended earlier, according to NCPA reporting.

What this means for patients with existing compounded GLP-1 prescriptions. Patients should talk with their prescriber about legal options. These may include FDA-approved products or customized formulations that are clinically justified and compliant. Patients should also ask any pharmacy directly how it is complying with the current rules.

A red flag in 2026. Any pharmacy still advertising generic compounded semaglutide or tirzepatide “copies” as a standard product should be treated with serious caution.

Texas-Specific Physician-Ownership and Anti-Kickback Safeguards

Texas has paid particular attention to financial ties between physicians and compounding pharmacies. A state senator raised concerns that compounding pharmacies were recruiting physicians as investors to get around kickback laws. In response, Texas law gave TSBP authority to examine the financial records of a pharmacy under investigation.

Physician investment is legal under Texas’s Solicitation of Patients statute, but only when it is structured correctly. The reported limits are:

• No more than 40% of a pharmacy may be owned by people in a position to make or influence referrals.
• No more than 40% of pharmacy income may come from physician investors.

These limits matter most to prescribers. Referral relationships with a compounder must be structured to avoid exposure under the federal Stark Law and Anti-Kickback Statute, and to withstand TSBP scrutiny. Very little Houston pharmacy content addresses this compliance issue, yet it is essential due diligence for any provider.

The Patient & Provider Vetting Framework: How to Evaluate Any Houston Compounding Pharmacy

The following seven-step checklist works for any Houston-area pharmacy or any nationwide-licensed compounder that ships into Texas.

Step 1: Confirm Active TSBP Licensing and Compliance Status

• Verify the pharmacy’s license directly through TSBP’s online license verification.
• If sterile products are needed, confirm the pharmacy operates under the March 1, 2026 rules.
• Check the FDA’s records of compounding inspections, recalls, and warning letters for any history involving the pharmacy.

Step 2: Look for PCAB Accreditation

PCAB (Pharmacy Compounding Accreditation Board) is widely regarded as the premier voluntary accreditation for compounding pharmacies. Key facts:

• It is administered through ACHC.
• It provides independent, third-party verification of compliance with USP 795, 797, and 800.
• It was established in 2007 by eight national pharmacy organizations, including the American Pharmacists Association (APhA), the National Association of Boards of Pharmacy (NABP), and the United States Pharmacopeia (USP).

Patients and providers should ask to see the accreditation certificate, not just a badge on a website.

Step 3: Verify USP 795/797/800 Compliance in Practice

The three core USP chapters are:

• USP 795: standards for non-sterile compounding, such as creams, capsules, and liquids.
• USP 797: standards for sterile compounding, such as injectables and pellets.
• USP 800: standards for safely handling hazardous drugs.

The revised 795 and 797 chapters became official on November 1, 2023, and USP 800 has been enforceable since the same date. Useful questions to ask:

• Does the pharmacy compound sterile products on-site?
• How often does it perform media-fill testing?

Step 4: Demand Evidence of Independent Third-Party Testing and Ingredient Sourcing

• Testing: Potency and sterility testing by an independent lab provides stronger verification than internal quality checks alone.
• Sourcing: Ask whether active ingredients come from FDA-inspected or FDA-cleared vendors.
• Red flag: A pharmacy that will not explain its sourcing or testing practices.

Step 5: Scrutinize Physician-Ownership and Referral Relationships

• Use the Texas 40% ownership and income limits as a screening question.
• Patients may ask their prescriber whether they hold a financial interest in the pharmacy they recommend.
• Normal clinical collaboration, such as discussing a formulation or dosage form, is appropriate. An undisclosed financial incentive is a different matter.

Step 6: Confirm GLP-1 and Sterile Product Compliance Post-2025 Deadlines

• Ask how the pharmacy changed its GLP-1 offerings after the April and May 2025 deadlines.
• Avoid pharmacies that still market generic “copy” formulations of semaglutide or tirzepatide.
• Confirm that any customized formulation is clinically differentiated from the brand product, not a workaround.

Step 7: Evaluate Service Breadth, Turnaround, and Communication Channels

• Fit: Confirm the pharmacy handles the specific need, whether BHRT, pediatric liquids, pain creams, dermatology, sports medicine, or veterinary medications.
• Speed: A common benchmark is a 1 to 2 business day turnaround, with same-day pickup for some medications.
• Communication: Check for secure provider and patient portals for submitting prescriptions, requesting refills, and getting support.

Houston’s Compounding Landscape: Context for Comparison

Houston’s compounding market is broad. A few examples illustrate the range:

• Village Compounding Pharmacy has operated since 1979. It is a PCCA and IACP member and is ACHC accredited.
• Physicians Preference Pharmacy, in the Katy/Houston area, focuses on BHRT and thyroid treatment.
• Magnolia Pharmacy holds CCE accreditation and offers BHRT, low dose naltrexone (LDN), dermatology, pain, pediatric, and GI formulations.
• BCP Veterinary Pharmacy has compounded exclusively for animals in Houston since 1995 and sources ingredients from FDA-approved facilities.

Across these providers, patients seek compounding for similar reasons:

• Removing an allergen from a medication
• Converting a pill into a liquid for a child or anyone who cannot swallow tablets
• Recreating a discontinued strength
• Using a non-standard delivery form

No single Houston resource, however, combines human sterile and non-sterile, hormone, pediatric, pain, dermatology, sports medicine, and GLP-1-compliant compounding with full regulatory transparency. In every case, a compounded medication requires a prescription under federal and state guidelines.

How Nationwide Compounding Meets the Houston Vetting Bar

The checklist above provides a fair way to evaluate any provider. Applied to Nationwide Compounding Rx®, which is based in Scottsdale, Arizona, the results are:

Vetting Criterion	Nationwide Compounding Rx Credential
Accreditation	PCAB Accredited
Hazardous drug handling	USP 800 Compliant
Quality verification	Independent third-party testing
Ingredient sourcing	High-grade chemicals from FDA-inspected and cleared vendors
Turnaround	1 to 2 business days; same-day pickup for some medications
Experience	40+ years of combined team experience

The pharmacy publishes a three-tier state licensing and shipping map:

1. Fully licensed states
2. Non-sterile only, with sterile licensing pending
3. Sterile and non-sterile licensing pending, or unlicensed

This lets Houston patients and providers confirm Texas service availability for a given medication type before ordering. Nationwide shipping depends on the medication type, state regulations, and prescription requirements.

The Connect, Collaborate, Create, Care Framework for Houston Prescribers

Nationwide Compounding Rx organizes its provider relationships around four stages:

• Connect: Physicians, clinics, med spas, and telehealth platforms start the relationship through the secure Provider Portal.
• Collaborate: The prescriber and pharmacy decide together on formulation, dosage form, and strength, based on the patient’s labs and needs.
• Create: The medication is compounded under PCAB- and USP-compliant processes, with quality verification.
• Care: The pharmacy manages refills, adjusts BHRT doses based on updated lab results, and supports patients through the Patient Portal.

A structured, documented framework like this reduces ambiguity and liability compared with informal, undocumented referral arrangements.

Full-Spectrum Service Menu for Houston Patients and Providers

Each specialty below addresses a specific clinical need and carries its own regulatory considerations.

Bioidentical Hormone Replacement Therapy (BHRT)

Customized formulations address menopause, andropause, and hormonal imbalance. Formulas can be adjusted at each refill based on new lab results. Houston has a strong BHRT market. Because hormone dosing must be precise, accreditation and testing are especially important here.

Pain Management Compounding

Topical creams, gels, and ointments deliver medication directly to the affected area. This approach can reduce systemic side effects, including addiction risk. Non-sterile topicals generally fall under USP 795 and TSBP oversight.

Dermatology Compounding

Custom topicals address acne, rosacea, eczema, psoriasis, atopic dermatitis, scarring, stretch marks, dark spots, and signs of aging. For patients with sensitive skin, formulations can be made without dyes, fillers, preservatives, or allergens.

Pediatric Compounding

Doses are tailored to age and weight for patients from newborns through teens. Kid-friendly forms include flavored liquids, popsicles, and suckers. Flavors include cherry, bubblegum, and marshmallow. These options directly address one of the most common reasons for compounding: children who cannot swallow tablets.

Sports Medicine Compounding

Personalized formulations support recovery, reduce inflammation, and aid performance within legal and regulatory limits. This service is relevant to Houston’s active population and its sports medicine clinics.

GLP-1/Peptide Support, Post-2025 Compliance

After the 2025 deadlines, compliant GLP-1 support means customized formulations that are not copies of brand products and are clinically justified for the individual patient. Patients should confirm any provider’s compliance approach before starting treatment.

Frequently Asked Questions: Compounding Pharmacies in Houston, Texas

Is compounded medication safe?
Safety depends on licensing, accreditation, USP compliance, and testing. The fact that a medication is available does not mean it is safe.

Is a prescription required?
Yes, in virtually all cases. A licensed prescriber must authorize the compounded medication.

Can a pharmacy outside Houston ship to Texas patients?
Yes, if it holds the proper Texas licensing. Tiered licensing maps, like the one described above, show which product types (sterile, non-sterile, or both) a pharmacy can ship to each state.

Is compounded semaglutide or tirzepatide still legal in 2026?
Only in narrow circumstances. Copies of FDA-approved drugs are no longer allowed, but clinically justified customized formulations may still be permitted.

How does a compounding pharmacy differ from a retail pharmacy?
A retail pharmacy dispenses mass-produced medications. A compounding pharmacy prepares a medication customized to an individual patient’s needs.

How can someone verify a pharmacy’s TSBP license or PCAB accreditation?
Use TSBP’s license verification tool and ACHC’s accreditation resources.

Conclusion: Choosing a Compounding Partner With Confidence in 2026

Houston patients and prescribers no longer have to rely on guesswork. A repeatable framework now applies to any compounder, local or nationwide. Its core pillars are:

• TSBP licensing and compliance with the March 1, 2026 sterile rules
• A clear understanding of 503A versus 503B pharmacies
• Verified PCAB accreditation and USP 795, 797, and 800 compliance
• Independent third-party testing and transparent ingredient sourcing
• GLP-1 compliance after the 2025 enforcement deadlines
• Adherence to Texas physician-ownership safeguards

This due diligence protects patient safety and limits prescriber liability, reflecting the lessons of the NECC outbreak. Nationwide Compounding Rx® is one example of a provider that openly documents how it meets each criterion through a licensed, accredited, multi-specialty model.

Next Steps: Connect With a Compliant Compounding Partner

• Patients: Apply the seven-step checklist before choosing any Houston-area or nationwide compounding pharmacy.
• Prescribers: Begin the Connect stage through the Nationwide Compounding Rx Provider Portal to set up a compliant partnership.
• Existing patients: Manage refills and support requests through the Patient Portal.
• Before submitting a prescription: Confirm Texas’s licensing tier and the specific service needed, whether BHRT, pediatric, pain, dermatology, sports medicine, or GLP-1.

Contact Nationwide Compounding Rx®:

• Phone: (480) 499-8379
• Website: nationwidecompounding.com
• Hours: Monday through Friday, 7:00 AM to 3:30 PM (Arizona time)